Narrative Review Explores Alistipes Genus Role in Inflammatory and CancersAlistipes bacteria may hold new hope for inflammatory bowel diseases and digestive cancer

This is a narrative review that examines the role of the Alistipes genus and its metabolites across several conditions, including inflammatory bowel diseases, digestive cancer, lung cancer, prostate cancer, and bladder cancer. The authors synthesize available evidence from human studies, though specific study designs, sample sizes, and settings are not detailed.

The review discusses potential mechanisms by which Alistipes may influence disease pathogenesis, focusing on its metabolites. The authors emphasize prospects for potential clinical value in diagnostics and therapeutics, suggesting that Alistipes could serve as a biomarker or therapeutic target.

However, the review does not report pooled effect sizes, primary outcomes, or comparator data, reflecting its narrative rather than systematic or meta-analytic approach. Limitations are not explicitly stated, but the absence of quantitative synthesis and reliance on observational data warrant cautious interpretation.

For clinicians, the review provides a broad overview of emerging research on Alistipes but does not offer actionable clinical recommendations. The evidence is preliminary, and further rigorous studies are needed to establish causality and clinical utility.